133825-81-7
中文名称
NEVANIMIBE HYDROCHLORIDE
英文名称
PD 132301-2
CAS
133825-81-7
更新日期
2023/03/20 15:41:21
分子式
C27H40ClN3O
分子量
458.09
MOL 文件
133825-81-7.mol
133825-81-7 结构式
基本信息
中文别名
化合物NEVANIMIBE HYDROCHLORIDE 英文别名
ATR-101 HClPD 132301-2
Nevanimibe)
ATR-101 (PD-132301
ATR101 hydrochloride
PD-132301 hydrochloride
Nevanimibe hydrochloride
物理化学性质
储存条件4°C, away from moisture
溶解度DMSO : 41.67 mg/mL (90.97 mM; Need ultrasonic)| (insoluble)
形态Solid
颜色White to off-white
水溶解性Water : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)
InChI1S/C27H39N3O.ClH/c1-19(2)23-10-9-11-24(20(3)4)25(23)29-26(31)28-18-27(16-7-8-17-27)21-12-14-22(15-13-21)30(5)6;/h9-15,19-20H,7-8,16-18H2,1-6H3,(H2,28,29,31);1H
InChIKeySDOOGTHIDFZUNM-UHFFFAOYSA-N
SMILES[Cl-].N(C)(C)c1ccc(cc1)C3(CCCC3)CNC(=O)Nc2c(cccc2C(C)C)C(C)C.[H+]
NEVANIMIBE HYDROCHLORIDE价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/12/22 | HY-100399A | NEVANIMIBE HYDROCHLORIDE Nevanimibe hydrochloride | 133825-81-7 | 1 mg | 500元 |
| 2025/12/22 | HY-100399A | NEVANIMIBE HYDROCHLORIDE Nevanimibe hydrochloride | 133825-81-7 | 5mg | 1000元 |
| 2025/12/22 | HY-100399A | NEVANIMIBE HYDROCHLORIDE Nevanimibe hydrochloride | 133825-81-7 | 10mM * 1mLin DMSO | 1008元 |
常见问题列表
生物活性
Nevanimibe hydrochloride (PD-132301 hydrochloride) 是一种口服有效的，选择性酰基辅酶 A：胆固醇 O-酰基转移酶 1 (ACAT1) 抑制剂，EC50 为 9 nM。Nevanimibe hydrochloride 抑制 ACAT2，EC50 为 368 nM。Nevanimibe hydrochloride 诱导细胞凋亡 (apoptosis)，并具有抗肾上腺皮质癌的潜力。靶点
|
ACAT1 9 nM (EC 50 ) |
ACAT2 368 nM (EC 50 ) |
体外研究
Coincubation of Nevanimibe hydrochloride (PD-132301 hydrochloride; ATR101 hydrochloride; 3 nM-30 μM) and Cholesterol markedly increases toxicity in a dose-dependent manner, where 3 nM Nevanimibe in the presence of 60 μg/mL Cholesterol reduces survival by 60% after 24 hours. All doses of Nevanimibe (3 nM-30 μM) induces cytoxicity in the presence of Cholesterol, whereas treatment with Cholesterol in the absence of Nevanimibe has no effect on cell viability.
Cell Cytotoxicity Assay
| Cell Line: | The H295R and HAC clone 15 (HAC15) human ACC cell lines |
| Concentration: | 3 nM-30 μM |
| Incubation Time: | 24 hours |
| Result: | 3 nM-3 μM exhibited no toxicity, whereas 30 μM treatment reduced survival by approximately 40% within 24 hours. |